ROCHE HIVID 0.750 (Hivid 0.75 mg)

Generic Name: zalcitabine

Pill imprint ROCHE HIVID 0.750 has been identified as Hivid 0.75 mg.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.75 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for ROCHE HIVID 0.750 (Hivid 0.75 mg)

Hivid 0.75 mg ROCHE HIVID 0.750
Hivid 0.75 mg ROCHE HIVID 0.750
Hivid
Generic Name:
zalcitabine
Imprint:
ROCHE
HIVID 0.750
Strength:
0.75 mg
Color:
White
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0221

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)